胰島素樣生長因子結(jié)合蛋白7(IGFBP7)重組蛋白
Recombinant Insulin Like Growth Factor Binding Protein 7 (IGFBP7)
FSTL2; IGFBP-7v; MAC25; PSF; TAF; IGFBP-rP1; MAC25 protein; Prostacyclin-stimulating factor; PGI2-stimulating factor; Tumor-derived adhesion factor
- 編號RPB673Hu02
 - 物種Homo sapiens (Human,人)相同的名稱,不同的物種。
 - 來源原核表達(dá)
 - 宿主E.coli
 - 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
 - 亞細(xì)胞定位分泌
 - 預(yù)測分子量56.0kDa
 - 實(shí)際分子量61kDa(差異分析請參閱說明書)
 - 片段與標(biāo)簽Asp30~Leu282 with N-terminal His and GST Tag
 - 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
 - 性狀凍干粉
 - 純度> 80%
 - 等電點(diǎn)7.8
 - 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載英文說明書 中文說明書
 - 規(guī)格10μg50μg200μg1mg5mg
 - 價格¥ 852¥ 2130¥ 4260¥ 12780¥ 31950
 - 欲了解實(shí)際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
序列

用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| RPB673Hu01 | 胰島素樣生長因子結(jié)合蛋白7(IGFBP7)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPB673Hu03 | 胰島素樣生長因子結(jié)合蛋白7(IGFBP7)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPB673Hu02 | 胰島素樣生長因子結(jié)合蛋白7(IGFBP7)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAB673Hu01 | 胰島素樣生長因子結(jié)合蛋白7(IGFBP7)多克隆抗體 | WB; IHC; ICC; IP. | 
| MAB673Hu22 | 胰島素樣生長因子結(jié)合蛋白7(IGFBP7)單克隆抗體 | WB; IHC; ICC; IP. | 
| SEB673Hu | 胰島素樣生長因子結(jié)合蛋白7(IGFBP7)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| SCB673Hu | 胰島素樣生長因子結(jié)合蛋白7(IGFBP7)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. | 
| LMB673Hu | 胰島素樣生長因子結(jié)合蛋白7(IGFBP7)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| PLoS One | Role of IGFBP7 in Diabetic Nephropathy: TGF-β1 Induces IGFBP7 via Smad2/4 in Human Renal Proximal Tubular Epithelial Cells[Pubmed:26974954] | 
| PLOS?ONE | Role?of?IGFBP7?in?Diabetic?Nephropathy:?TGF-β1 Induces?IGFBP7?via Smad2/4 in Human Renal Proximal Tubular Epithelial Cells.[pubmed:26974954] | 
| Journal of?Alzheimers?Disease | Urine-Based Biomarkers for Alzheimer's Disease Identified Through Coupling Computational and Experimental Methods[Pubmed:30040720] | 
| Cancers (Basel). | IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer[Pubmed: 30609749] | 
| Advances in?Medical?Sciences | Insulin-like growth factor-binding protein 7 (IGFBP 7) as a new biomarker in coronary heart disease[Pubmed: 30769262] | 
| PLoS One | Altered insulin-like growth factor-2 signaling is associated with psychopathology and cognitive deficits in patients with schizophrenia[Pubmed: 32191705] | 
| Scientific reports | Discovery of novel biomarkers for atherosclerotic aortic aneurysm through proteomics-based assessment of disease progression[Pubmed: 32286426] | 
| Genet Med | SNORD116 and growth hormone therapy impact IGFBP7 in Prader¨CWilli syndrome[34040195] | 
| Sci Rep | Biomarkers of persistent renal vulnerability after acute kidney injury recovery[34707157] | 
| Biomolecules | IGFBP7 Concentration May Reflect Subclinical Myocardial Damage and Kidney Function in Patients with Stable Ischemic Heart Disease[Pubmed:35204773] | 
| Biomolecules | Insulin-Like Growth Factor-Binding Protein 7 (IGFBP-7)—New Diagnostic and Prognostic Marker in Symptomatic Peripheral Arterial Disease?—Pilot Study[Pubmed:35625639] | 



